Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled “Myriad Pro-Con.” Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) “gene patenting” case.
Related News
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."
August 1, 2025
In the News
Aaron Maguregui Assesses HIPAA Challenges as AI Advances in Health Care
Foley & Lardner LLP partner Aaron Maguregui commented in the Medical Device Network article, "AI proliferation in healthcare shines light on HIPAA shortcomings," assessing the rise and accompanying risks of artificial intelligence in health care.
August 1, 2025
In the News
Louis Lehot Assesses Figma IPO
Foley & Lardner LLP partner Louis Lehot commented on a major technology initial public offering in the Business Insider article, "Lina Kahn is taking a victory lap over the Figma IPO."